Le Scienze publishes a feature on Hemera and REMaST® in regenerative medicine for the nervous system

Apr 29, 2026 | News, Press Review

Hemera is featured in the article published in Le Scienze (May issue), the Italian edition of Scientific American, one of the oldest and most authoritative international scientific magazines, focusing on the development of the REMaST® platform for spinal cord injury...

The importance of scientific communication: Cristiana Vignoli interviewed by Touchpoint on the REMaST® challenge

Apr 1, 2026 | News, Press Review

Touchpoint, an editorial publication focused on the intersection between markets and innovation, dedicated a feature in its February–March print edition to Hemera, including an interview with Cristiana Vignoli, Chief Executive Officer of the company. The interview...

REMaST® and the publication in Immunity: growing media attention on the therapeutic platform and its clinical development potential

Mar 27, 2026 | News, Press Review

In January 2026, following the dissemination of the scientific preprint on the cell therapy REMaST published in the international scientific journal Immunity by Cell Press,Hemera received significant national media coverage, confirming the growing interest in...

Osservatorio Terapie Avanzate features Hemera and the regenerative medicine challenge behind REMaST®

Mar 23, 2026 | News, Press Review

Hemera is featured in an article published by Osservatorio Terapie Avanzate, a leading Italian editorial platform focused on scientific information and analysis of innovations in advanced therapies, regenerative medicine, and biotechnology. In the interview, Cristiana...

TG3 Leonardo features an in-depth report on REMaST® and macrophage-based research for nervous system regeneration

Jan 27, 2026 | News, Press Review

The cell therapy REMaST, developed by Hemera for the regeneration of nervous tissue in spinal cord injuries, was the focus of a dedicated report on TG3 Leonardo, the Italian public broadcaster’s science and technology program. The segment highlighted the innovative...

Hemera Presents the Progress of REMaST®️ Therapy at the FENS Forum 2024

Jun 28, 2024 | News, Press Review

We are excited to announce our participation in the FENS Forum 2024, the largest European congress dedicated to neuroscience, taking place from June 25 to 29 in Vienna. The teams from the Therapy Development Department and the Research and Development Department,...